Alpha memo: resveratrol exercise context boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• Receipt 2 abstract excerpt appears truncated mid-sentence at '45'; memo treats the 45% figure as an exercise adaptation but the bundle text cuts off before specifying whether 45% refers to the MAP reduction magnitude or another parameter — minor presentation ambiguity rather than a substantive overclaim.
• Title phrase 'resveratrol exercise context boundary' is slightly opaque but the memo's one-sentence alpha makes the boundary explicit.

Reviewer note

The memo makes one bounded research signal explicit: resveratrol + exercise is not uniformly synergistic, and the two cited RCTs differ across population (functionally limited older adults vs healthy inactive aged men), endpoint family (safety/feasibility + physical function + mitochondrial outcomes vs cardiovascular/MAP), and dose (500/1000 mg vs 250 mg), so the apparent divergence is reframed as a context-dependent split. The one-sentence alpha is clear and proportionate. Evidence Landscape integrates the two receipts into a coherent argument about why the divergence is plausibly a population/endpoint/dose split rather than contradiction, and the Caveats/falsifiers section is specific and material: it flags the pilot-vs-confirmatory distinction, the small n, the dose mismatch, and proposes an adequately powered matched-dose falsifier. Both bundle entries correspond to real, well-known primary trials (Harper et al. 2021 Exp Gerontol; Gliemann et al. 2013 J Physiol), and the cited details (N=60, age ~71.8, three-arm 12-week design; n=27 aged men, 65±1 y, MAP 95.8±2.2 mmHg, 250 mg trans-resveratrol, 8 weeks, 45% training effect) match the abstracts. Claims stay proportionate to the receipts: the memo does not assert efficacy, synergy, or broad consensus, and uses language consistent with the evidence (feasibility/safety, 'blunted', 'context-dependent split'). No clinical, policy, or investment claims are made. No instructions embedded in the manuscript. Title/source alignment is fine — both receipts are resveratrol + exercise RCTs. Recommend accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis